[MRNA]

Mid
보유종목에 대한 모든 정보 확인이 가능합니다. | 원문 보기
Mid 2026-08-01 01:07:39
Moderna reiterates up to 10% 2026 revenue growth while lowering cash cost guidance to ~$4B
Row 2026-07-31 20:32:15
Moderna slips as trial setback overshadows Q2 beat
Row 2026-07-31 20:16:51
Earnings Snapshot: Moderna sees 55% of H2 revenue in Q3, reiterates 2026 growth target as norovirus trial misses early metric
Mid 2026-07-31 20:08:46
Moderna beats top-line and bottom-line estimates; reaffirms FY outlook
Mid 2026-07-31 04:35:15
Moderna Q2 preview - cash burn, vaccine sales on focus
1 / 2